What are the compliance requirements for sequence listings in patent applications?

This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.

According to MPEP 2422.07, patent applications must comply with the requirements of 37 CFR 1.821(b) through (e) for sequence listings. The section states:

“37 CFR 1.821(g) requires compliance with the requirements of 37 CFR 1.821(b) through (e) , as discussed above, if they are not satisfied at the time of filing under 35 U.S.C. 111(a) or at the time of entering the national stage of an international application under 35 U.S.C. 371 , within the period of time set in a notice requiring compliance.”

This means that if the sequence listing requirements are not met at the time of filing, applicants must comply within a specified period.